Short, sharp blast of radiation aims to zap returning prostate cancer
NCT ID NCT05746806
Summary
This study is testing a new, shorter radiation treatment for men whose prostate cancer has come back in the area where the prostate was removed. The treatment involves just five high-dose radiation sessions, combined with six months of hormone-blocking drugs. Researchers want to see if this approach is effective at keeping the cancer under control and safe for patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Inselgruppe AG, Inselspital
Bern, 3010, Switzerland
-
Istituto Oncologico della Svizzera Italiana-Ente Ospedaliero Cantonale (IOSI-EOC)
Bellinzona, 6500, Switzerland
-
Kantonsspital Winterthur, Klinik für Radio-Onkologie
Winterthur, 8401, Switzerland
-
Universitätsspital Basel
Basel, 4031, Switzerland
-
Universitätsspital Zürich, Klinik für Radio-Onkologie
Zurich, 8091, Switzerland
Conditions
Explore the condition pages connected to this study.